FDA-approved dual GIP/GLP-1 agonist showing superior weight loss vs semaglutide — up to 22.5% body weight in SURMOUNT-1 trial.
Pre-filled with standard Tirzepatide values. Adjust as needed.
Titration: 2.5mg × 4 wks, increase by 2.5mg every 4 weeks to 10–15mg maintenance. Track glucose, ApoB, weight monthly.
Blood markers to track
Note: FDA-approved as Mounjaro (T2D) and Zepbound (obesity). Superior weight loss vs semaglutide. Same GI side effect profile.
Log HbA1c and Fasting glucose across draws and let StackAI analyze your response. Free to start.
Track my Tirzepatide labs free →